Canada House Wellness Group, a fully integrated medical cannabis company, is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. has surpassed 650 active medical patient registrations, 400 of which are military Veterans. The achievement of these milestones follows the recent release of Veterans Kush, a cultivar developed specifically for Veterans with PTSD, exclusively to registered Abba patients.
Both the Company’s clinic division, Canada House Clinics (CHC), and Abba on the medical market, have an orientation to serving the Veteran market in Canada, including providing services and support beyond medical cannabis. CHC also continues to see growth in its Veteran patient base, with recent initiatives accelerating growth to exceed 3,100 active Veteran medical registrations across Canada.
“We have received nothing but positive reviews with respect to the Veterans Kush strain and the relief it has provided our patients,” commented Alex Kroon, President of Canada House Clinics. “Our medical educators help patients find the right medical cannabis treatment plan for them. The offering by a Veteran focused LP of a strain developed specifically for Veterans with PTSD has enhanced the support we are able to provide for our Veteran patients.”
“The response to our launch of Veterans Kush as an exclusive offering to registered Abba patients has been incredible,” added Canada House CEO, Chris Churchill-Smith. “We are very pleased with the patient growth we are experiencing and will continue to concentrate on delivering top quality cannabis products and services to our patients.”
Canada House Wellness Group is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility employing state-of-the-art vertical, aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.
Canada House Wellness Group’s goal is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally. Please visit www.canadahouse.ca
